**
Overview
Mitochondrial Myopathies are a diverse group of conditions that affect the mitochondria, the energy-producing structures within cells. Mitochondrial myopathies are caused by mutations in mitochondrial DNA (mtDNA) or nuclear DNA (nDNA) that affect the function of the mitochondria. This impairment leads to a decrease in energy production, resulting in muscle weakness, fatigue, and other systemic symptoms. Mitochondrial myopathies can affect individuals of all ages, from infants to adults, and can be inherited in an autosomal dominant, autosomal recessive, or maternal pattern.
History/Background
The first descriptions of mitochondrial myopathies date back to the 1960s, when researchers identified a group of patients with muscle weakness and degeneration. However, it wasn't until the 1980s that the genetic basis of these conditions was understood. The discovery of mtDNA mutations in patients with mitochondrial myopathies led to a greater understanding of the role of mitochondria in energy production and the development of diagnostic tests for these conditions. Today, mitochondrial myopathies are recognized as a distinct group of disorders, with over 150 different mtDNA mutations identified.
Key Information
Mitochondrial myopathies can be classified into several subtypes, including:
* Kearns-Sayre Syndrome: a rare condition characterized by progressive external ophthalmoplegia, muscle weakness, and cardiac conduction defects.
* Myoclonic Epilepsy with Ragged-Red Fibers (MERRF): a condition characterized by myoclonic seizures, muscle weakness, and ragged-red fibers on muscle biopsy.
* NARP Syndrome: a condition characterized by neuropathy, ataxia, and retinitis pigmentosa.
* Leigh Syndrome: a condition characterized by progressive brain degeneration, muscle weakness, and seizures.
Symptoms of mitochondrial myopathies can vary widely depending on the subtype and individual affected. Common symptoms include:
* Muscle weakness and fatigue
* Muscle pain and cramping
* Seizures and epilepsy
* Vision loss and blindness
* Hearing loss and deafness
* Cardiac conduction defects and arrhythmias
Significance
Mitochondrial myopathies are significant because they highlight the importance of mitochondrial function in maintaining cellular energy production. Understanding the genetic basis of these conditions has led to the development of diagnostic tests and treatments, such as gene therapy and mitochondrial-targeted antioxidants. Additionally, research on mitochondrial myopathies has shed light on the role of mitochondria in aging and age-related diseases, such as Alzheimer's and Parkinson's.
INFOBOX:
- Name: Mitochondrial Myopathies
- Type: Genetic disorder
- Date: 1960s (first descriptions)
- Location: Worldwide
- Known For: Impaired mitochondrial function leading to muscle weakness and degeneration
TAGS: Mitochondrial myopathies, genetic disorders, muscle weakness, fatigue, seizures, epilepsy, vision loss, hearing loss, cardiac conduction defects, gene therapy, mitochondrial-targeted antioxidants.
